Alopecia Areata: Exploring New Data

DermConsult
29/03/2023 9 min

Listen "Alopecia Areata: Exploring New Data "

Descargar episodio Ver en sitio original

Episode Synopsis



Host: Raj Chovatiya, MD, PhD

Guest: Britt Craiglow, MD



Initially approved for the treatment of rheumatoid arthritis, baricitinib is now the first FDA-approved treatment for patients with alopecia areata. So what can patients look forward to with this new therapy? Dive in with Dr. Raj Chovatiya as he’s joined by Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist at Dermatology Physicians of Connecticut.

More episodes of the podcast DermConsult

Unmasking Psoriasis in Skin of Color: Clinical Clues and Care Strategies 07/11/2025
Targeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab 21/10/2025
Chronic Hand Eczema: Guideline-Based Strategies for Diagnosis and Management 21/10/2025
Examining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials 21/10/2025
Applying Guidelines to Chronic Hand Eczema Care: A Case-Based Approach 21/10/2025
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics 16/10/2025
Understanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses 10/10/2025
Advancing Care for Coexisting Psoriasis and Seborrheic Dermatitis 10/10/2025
What's New in Dermatology: Key Updates on Emerging Therapies 04/06/2025
Racial Disparities in Atopic Dermatitis Care: Improving Education, Access, and Research 21/01/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA